Foodservice Quality Tech
Medical Care Technologies Positions StrainScan Pro for $4 Trillion Global Foodservice Market via iPad Air Installations
Medical Care Technologies Inc. (OTC Pink: MDCE) is moving its AI-powered StrainScan Pro platform into the global foodservice market, targeting restaurants and commercial kitchens. The company says the market is worth $4 trillion, according to The Olympian.
StrainScan Pro runs on iPad Air hardware. It lets kitchen staff run real-time visual quality checks without bulky, fixed equipment. MDCE says this makes it easy to roll out across multi-location restaurant groups.
StrainScan Pro Targets Restaurants With iPad-Based Quality Checks
StrainScan Pro is designed as a portable, on-device solution. It installs directly on Apple iPad Air tablets. Staff can use it to visually monitor food quality in real time, according to Sacramento Bee. No complex fixed systems are needed. That makes setup fast and cheap for operators running multiple locations.
The platform uses AI vision technology to flag quality issues. MDCE says the tool is built for high-volume food operations. Think busy kitchens, fast-casual chains, and large catering operations. The company has not yet disclosed pricing for enterprise installations.
MDCE Pushes AI Vision Tech Across Multiple High-Value Industries
StrainScan Pro's foodservice push is part of a broader strategy, according to The News Tribune. MDCE is applying its AI vision technology across several high-value sectors. The company first developed the platform for medical and cannabis use cases before pivoting toward commercial food operations.
MDCE also runs two other revenue-generating subsidiaries. One is Infinite Auctions. The other is Real Game Used, which deals in sports memorabilia. These units are meant to generate cash while the company builds out its core AI platform.
Company Cites $4 Trillion Market but Offers Few Hard Numbers
MDCE's press release leans on the $4 trillion global foodservice market figure to frame its opportunity, according to Ledger-Enquirer. But the company has not shared specific sales targets, signed contracts, or revenue projections tied to this launch. Investors should note MDCE trades on the OTC Pink market, which has lighter disclosure rules than major exchanges.
The company included standard forward-looking statement warnings. It noted that actual results may differ from expectations due to risks and uncertainties. That language is common in press releases but signals that no firm deals are in place yet.
What Comes Next for MDCE and StrainScan Pro
MDCE has not announced a specific launch date or named any restaurant partners. The company says the iPad Air model supports a straightforward rollout. If it can sign even a small regional chain, that would mark a concrete step toward proving the platform's commercial value.
For now, the foodservice push remains an intention, not a signed deal. Watchers of the OTC Pink market know that press releases about large addressable markets are common. Execution and customer contracts are what separate announcements from results.
Sentiment
NeutralPublishers
4
Articles
4
Reach
4
